Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.940
+0.180 (3.78%)
At close: Mar 10, 2026
86.42%
Market Cap 1.16B
Revenue (ttm) 22.86M
Net Income (ttm) -97.88M
Shares Out 243.42M
EPS (ttm) -0.40
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 167,800
Average Volume 258,315
Open 4.780
Previous Close 4.760
Day's Range 4.780 - 4.980
52-Week Range 1.700 - 10.770
Beta -0.18
RSI 40.74
Earnings Date Mar 27, 2026

About HKG:2185

Shanghai Bio-heart Biological Technology Co., Ltd. an interventional cardiovascular device company, engages in the research and development of therapies for unmet medical needs of patients in the People’s Republic of China. The company develops Bioheart, a bioresorbable scaffolds (BRS) system used in percutaneous coronary intervention procedures for the treatment of coronary artery disease; Iberis 2nd, a renal denervation (RDN) product candidate for the treatment of uncontrolled hypertension and resistant hypertension; and drug coated balloon (... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 70
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2185
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.